Asset Allocation
| Position | Category/Sector | Target Weight |
|---|---|---|
NVDA NVIDIA Corporation | Technology | 20% |
VST Vistra Corp. | Utilities | 20% |
BSX Boston Scientific Corporation | Healthcare | 20% |
VRNA Verona Pharma plc | Healthcare | 20% |
NRG NRG Energy, Inc. | Utilities | 10% |
PLTR Palantir Technologies Inc. | Technology | 10% |
Find the right asset allocation for Optimised Sharpe ratio 15-08-2025
Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio OptimizerPerformance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Optimised Sharpe ratio 15-08-2025, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is never rebalanced.
Loading charts...
Returns By Period
| Position | 1D | 1M | YTD | 6M | 1Y | 3Y* | 5Y* | 10Y* |
|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | -1.44% | -1.45% | 7.60% | 6.59% | 22.24% | 19.20% | 11.54% | 13.71% |
Portfolio Optimised Sharpe ratio 15-08-2025 | -2.07% | -3.94% | -6.67% | -8.41% | 2.88% | 68.23% | 50.43% | — |
| Portfolio components: | ||||||||
BSX Boston Scientific Corporation | 2.86% | -21.08% | -52.18% | -52.54% | -55.45% | -5.46% | 0.85% | 7.38% |
NRG NRG Energy, Inc. | -0.90% | 0.01% | -13.02% | -12.39% | -8.43% | 61.61% | 33.25% | 28.30% |
NVDA NVIDIA Corporation | -4.13% | -6.99% | 7.39% | 5.85% | 38.94% | 68.08% | 59.90% | 67.94% |
PLTR Palantir Technologies Inc. | -2.34% | -14.74% | -34.35% | -39.89% | -16.60% | 102.61% | 34.48% | — |
VRNA Verona Pharma plc | — | — | — | — | — | — | — | — |
VST Vistra Corp. | -2.91% | 4.06% | 0.94% | 0.72% | -12.49% | 88.21% | 57.72% | — |
Monthly Returns
Based on dividend-adjusted daily data since Sep 30, 2020, Optimised Sharpe ratio 15-08-2025's average daily return is +0.18%, while the average monthly return is +3.72%. At this rate, an investment would double in approximately 1.6 years.
Historically, 61% of months were positive and 39% were negative. The best month was Nov 2020 with a return of +25.6%, while the worst month was Apr 2022 at -14.2%. The longest winning streak lasted 13 consecutive months, and the longest losing streak was 5 months.
On a daily basis, Optimised Sharpe ratio 15-08-2025 closed higher 54% of trading days. The best single day was Apr 9, 2025 with a return of +13.5%, while the worst single day was Jan 27, 2025 at -14.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -2.87% | -0.94% | -4.17% | 4.08% | 2.35% | -4.98% | -6.67% | ||||||
| 2025 | 9.89% | 1.09% | -9.29% | 12.19% | 18.22% | 13.78% | 10.14% | -3.24% | 5.33% | 3.43% | -6.99% | -0.41% | 63.55% |
| 2024 | 7.66% | 18.97% | 11.24% | 0.64% | 16.17% | 3.90% | 1.32% | 8.79% | 11.85% | 8.43% | 17.56% | -1.19% | 168.79% |
| 2023 | -1.59% | 1.37% | 4.86% | 1.64% | 13.02% | 5.80% | 7.10% | -1.74% | -6.68% | -5.74% | 10.35% | 12.17% | 45.68% |
| 2022 | -10.49% | -2.09% | 4.14% | -14.17% | 3.58% | -12.24% | 14.24% | 6.39% | -8.45% | 15.05% | 4.65% | 22.24% | 16.62% |
| 2021 | 13.38% | -6.99% | -2.03% | -0.84% | -2.76% | 13.90% | -2.69% | 6.81% | -7.58% | 8.20% | 0.57% | 4.81% | 24.31% |
Benchmark Metrics
Optimised Sharpe ratio 15-08-2025 has an annualized alpha of 28.99%, beta of 1.34, and R2 of 0.48 versus S&P 500 Index. Calculated based on daily prices since September 30, 2020.
- This portfolio captured 180.97% of S&P 500 Index gains but only 46.16% of its losses - a favorable profile for investors.
- R2 of 0.48 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 28.99%
- Beta
- 1.34
- R²
- 0.48
- Upside Capture
- 180.97%
- Downside Capture
- 46.16%
Expense Ratio
Optimised Sharpe ratio 15-08-2025 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
Optimised Sharpe ratio 15-08-2025 ranks 6 for risk / return — in the bottom 6% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below presents risk-adjusted performance metrics for Optimised Sharpe ratio 15-08-2025 and compares them with S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.13 | 1.78 | -1.66 |
| Sortino ratioReturn per unit of downside risk | 0.34 | 2.44 | -2.10 |
| Omega ratioGain probability vs. loss probability | 1.04 | 1.32 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | 0.16 | 2.46 | -2.30 |
| Martin ratioReturn relative to average drawdown | 0.31 | 10.92 | -10.61 |
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Position | Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio |
|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 2 | -1.58 | -2.46 | 0.65 | -0.94 | -2.00 |
NRG NRG Energy, Inc. | 33 | -0.19 | 0.04 | 1.01 | -0.25 | -0.59 |
NVDA NVIDIA Corporation | 72 | 1.10 | 1.65 | 1.20 | 1.94 | 4.51 |
PLTR Palantir Technologies Inc. | 29 | -0.32 | -0.13 | 0.98 | -0.38 | -0.75 |
VRNA Verona Pharma plc | — | — | — | — | — | — |
VST Vistra Corp. | 31 | -0.26 | -0.04 | 1.00 | -0.33 | -0.59 |
Loading charts...
Dividends
Dividend yield
Optimised Sharpe ratio 15-08-2025 provided a 0.27% dividend yield over the last twelve months.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 0.27% | 0.23% | 0.31% | 0.72% | 1.09% | 0.84% | 0.89% | 0.52% | 0.12% | 0.10% | 3.28% | 0.73% |
| Portfolio components: | ||||||||||||
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NRG NRG Energy, Inc. | 1.33% | 1.11% | 1.81% | 2.92% | 4.40% | 3.02% | 3.20% | 0.30% | 0.30% | 0.42% | 1.92% | 4.93% |
NVDA NVIDIA Corporation | 0.14% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
PLTR Palantir Technologies Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VRNA Verona Pharma plc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VST Vistra Corp. | 0.56% | 0.56% | 0.63% | 2.13% | 3.12% | 2.64% | 2.75% | 2.17% | 0.00% | 0.00% | 14.97% | 0.00% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Optimised Sharpe ratio 15-08-2025. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Optimised Sharpe ratio 15-08-2025 was 32.04%, occurring on Jun 16, 2022. Recovery took 129 trading sessions.
The current Optimised Sharpe ratio 15-08-2025 drawdown is 15.06%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Bear market2022 | -32.04%Jun 2022 | 5mo 20d | 6mo 7d | 11mo 27dDec 2021 - Dec 2022 |
2025 selloff2025 | -30.60%Apr 2025 | 1mo 14d | 1mo 10d | 2mo 24dFeb 2025 - May 2025 |
2021 bear market2021 | -26.11%May 2021 | 3mo 2d | 5mo 29d | 9mo 1dFeb 2021 - Nov 2021 |
2026 correction2026 | -18.41%Mar 2026 | 5mo 1d | — | 7mo 27dOct 2025 - now |
2024 correction2024 | -17.55%Aug 2024 | 25d | 10d | 1mo 5dJul 2024 - Aug 2024 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 6 assets, with an effective number of assets of 5.56, reflecting the diversification based on asset allocation. Your capital is spread almost evenly across your holdings, indicating a well-balanced allocation. Note that true diversification also depends on the correlations between assets — check the diversification ratio below.
Diversification Ratio
1Y | 3Y | 5Y | All Time | |
|---|---|---|---|---|
Diversification Ratio | 1.67 | 1.54 | 1.59 | 1.63 |
The portfolio has a diversification ratio of 1.63, in line with the typical range across portfolios. There's room to improve by adding less correlated assets.
Optimised Sharpe ratio 15-08-2025 correlation to the S&P 500 Index
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2020 | 0.67 |
Benchmark Correlations
Correlation vs. S&P 500 Index. NVDA has the highest benchmark correlation at 0.68, while VRNA has the lowest at 0.20.
Asset Correlations Table
Find what Optimised Sharpe ratio 15-08-2025 is missing
See which holdings overlap, where Optimised Sharpe ratio 15-08-2025 is concentrated, and which low-correlation assets could fill the gaps.
Analyze Diversification